123 related articles for article (PubMed ID: 22642152)
1. [Specificity of molecular recognition in oligomerization of bacterial L-asparaginases].
Mezentsev IuV; Mol'nar AA; Sokolov NN; Lisitsyna VB; Shatskaia MA; Ivanov AS; Archakov AI
Biomed Khim; 2012; 58(1):50-64. PubMed ID: 22642152
[TBL] [Abstract][Full Text] [Related]
2. Structure of Helicobacter pylori L-asparaginase at 1.4 A resolution.
Dhavala P; Papageorgiou AC
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1253-61. PubMed ID: 19966411
[TBL] [Abstract][Full Text] [Related]
3. [Oligomerization of L-asparaginase from Erwinia carotovora].
Mezentsev IuV; Mol'nar AA; Gnedenko OV; Krasotkina IuV; Sokolov NN; Ivanov AS
Biomed Khim; 2006; 52(3):258-71. PubMed ID: 16898584
[TBL] [Abstract][Full Text] [Related]
4. Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase.
Maggi M; Chiarelli LR; Valentini G; Scotti C
Biomolecules; 2015 Mar; 5(2):306-17. PubMed ID: 25826146
[TBL] [Abstract][Full Text] [Related]
5. Structures of two highly homologous bacterial L-asparaginases: a case of enantiomorphic space groups.
Jaskólski M; Kozak M; Lubkowski J; Palm G; Wlodawer A
Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):369-77. PubMed ID: 11223513
[TBL] [Abstract][Full Text] [Related]
6. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].
Sokolov NN; Eldarov MA; Pokrovskaya MV; Aleksandrova SS; Abakumova OY; Podobed OV; Melik-Nubarov NS; Kudryashova EV; Grishin DV; Archakov AI
Biomed Khim; 2015; 61(3):312-24. PubMed ID: 26215408
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure and amino acid sequence of Wolinella succinogenes L-asparaginase.
Lubkowski J; Palm GJ; Gilliland GL; Derst C; Röhm KH; Wlodawer A
Eur J Biochem; 1996 Oct; 241(1):201-7. PubMed ID: 8898907
[TBL] [Abstract][Full Text] [Related]
8. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification and crystallization of Helicobacter pylori L-asparaginase.
Dhavala P; Krasotkina J; Dubreuil C; Papageorgiou AC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Aug; 64(Pt 8):740-2. PubMed ID: 18678946
[TBL] [Abstract][Full Text] [Related]
10. Structure of the isoaspartyl peptidase with L-asparaginase activity from Escherichia coli.
Prahl A; Pazgier M; Hejazi M; Lockau W; Lubkowski J
Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1173-6. PubMed ID: 15159592
[TBL] [Abstract][Full Text] [Related]
11. Why a "benign" mutation kills enzyme activity. Structure-based analysis of the A176V mutant of Saccharomyces cerevisiae L-asparaginase I.
Bonthron DT; Jaskólski M
Acta Biochim Pol; 1997; 44(3):491-504. PubMed ID: 9511960
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent.
Cappelletti D; Chiarelli LR; Pasquetto MV; Stivala S; Valentini G; Scotti C
Biochem Biophys Res Commun; 2008 Dec; 377(4):1222-6. PubMed ID: 18983825
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I.
Yun MK; Nourse A; White SW; Rock CO; Heath RJ
J Mol Biol; 2007 Jun; 369(3):794-811. PubMed ID: 17451745
[TBL] [Abstract][Full Text] [Related]
14. Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants.
Maggi M; Chiarelli LR; Valentini G; Scotti C
PLoS One; 2015; 10(2):e0117025. PubMed ID: 25664771
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
Kotzia GA; Labrou NE
J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
[TBL] [Abstract][Full Text] [Related]
16. Human 60-kDa lysophospholipase contains an N-terminal L-asparaginase domain that is allosterically regulated by L-asparagine.
Karamitros CS; Konrad M
J Biol Chem; 2014 May; 289(19):12962-75. PubMed ID: 24657844
[TBL] [Abstract][Full Text] [Related]
17. Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.
Derst C; Henseling J; Röhm KH
Protein Sci; 2000 Oct; 9(10):2009-17. PubMed ID: 11106175
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action.
Bansal S; Srivastava A; Mukherjee G; Pandey R; Verma AK; Mishra P; Kundu B
FASEB J; 2012 Mar; 26(3):1161-71. PubMed ID: 22166247
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and preliminary crystallographic studies of a new L-asparaginase encoded by the Escherichia coli genome.
Borek D; Jaskólski M
Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1505-7. PubMed ID: 11053866
[TBL] [Abstract][Full Text] [Related]
20. [Suppression of telomerase activity leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase].
Pokrovskaya MV; Zhdanov DD; Eldarov MA; Aleksandrova SS; Veselovskiy AV; Pokrovskiy VS; Grishin DV; Gladilina JA; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):62-74. PubMed ID: 28251953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
